Senescence Gene Expression Profiles and 90-Day Outcome in Stroke Patients
Blood tests measuring cellular aging predict stroke recovery better than age alone, opening doors to recovery-boosting therapies.
This prospective Neurology cohort study links peripheral blood senescence gene signatures at acute stroke onset to 90-day functional recovery, demonstrating that biological aging burden—captured via transcriptomics—predicts stroke outcomes better than chronological age alone. The findings open a path toward senolytic interventions to improve stroke recovery and identify a new class of outcome biomarkers in acute neurology.
What the study was
- Study design
- Prospective cohort study with transcriptomic profiling
- Population
- Acute ischemic stroke patients with blood-based senescence gene expression profiling and 90-day functional outcome assessment
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Neurology
Why it surfaced
Novel senescence transcriptomic biomarker for stroke outcome in Neurology; bridges aging biology and acute neurology with potential to identify patients benefiting from senolytic interventions.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.